Axovant Sciences to Present at Upcoming Investor Conferences
February 27 2017 - 4:30PM
PR Newswire (US)
BASEL, Switzerland,
Feb. 27, 2017 /PRNewswire/
-- Axovant Sciences (NYSE: AXON), a leading
clinical-stage biopharmaceutical company focused on the treatment
of dementia, today announced upcoming presentations at three
investor conferences:
- March 6 at 3:20 p.m. ET at the Cowen and Company 37th Annual
Healthcare Conference
- March 14 at 10:45 a.m. ET at the Barclays Global Healthcare
Conference
- March 22 at 3:55 p.m. ET at the Oppenheimer 27th Annual
Healthcare Conference
A simultaneous webcast will be available for each conference in
the Investors section of Axovant's website at www.axovant.com. A
replay will be available for 30 days following each conference.
About Axovant Sciences
Axovant Sciences is a
leading clinical-stage biopharmaceutical company focused on
acquiring, developing and commercializing novel therapeutics for
the treatment of dementia. Axovant intends to develop a pipeline of
product candidates to comprehensively address the cognitive,
functional and behavioral aspects of dementia and related
neurological disorders. Our vision is to become the leading company
focused on the treatment of dementia by addressing all forms and
aspects of this condition.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/axovant-sciences-to-present-at-upcoming-investor-conferences-300414201.html
SOURCE Axovant Sciences
Copyright 2017 PR Newswire
Axon Enterprise (NASDAQ:AXON)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axon Enterprise (NASDAQ:AXON)
Historical Stock Chart
From Apr 2023 to Apr 2024